The Journal of Clinical and Aesthetic Dermatology

James Del Rosso, DO: New and Exciting Indications for Bimekizumab, Nemolizumab, and Lebrikizumab

JCAD

Dr. Del Rosso discusses three exciting new indications for drugs in dermatology and how these approvals will impact clinical practice.